Cargando…
Identification of RAD54 homolog B as a promising therapeutic target for breast cancer
Breast cancer is a recognized threat to the health of women globally. Due to the lack of the knowledge about the molecular pathogenesis of breast cancer, therapeutic strategies remain inadequate, especially for aggressive breast cancer. In the present study, sequential bioinformatics analysis was pe...
Autores principales: | Feng, Jing, Hu, Juanjuan, Xia, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781656/ https://www.ncbi.nlm.nih.gov/pubmed/31612045 http://dx.doi.org/10.3892/ol.2019.10854 |
Ejemplares similares
-
Rad54: the Swiss Army knife of homologous recombination?
por: Heyer, Wolf-Dietrich, et al.
Publicado: (2006) -
Rad53 regulates the lifetime of Rdh54 at homologous recombination intermediates
por: Hu, Jingyi, et al.
Publicado: (2023) -
The homologous recombination protein RAD51 is a promising therapeutic target for cervical carcinoma
por: Chen, Qian, et al.
Publicado: (2017) -
The role of Candida albicans homologous recombination factors Rad54 and Rdh54 in DNA damage sensitivity
por: Hoot, Samantha J, et al.
Publicado: (2011) -
Homologous recombination repair rathway and RAD54L in early-stage lung adenocarcinoma
por: Zheng, Shaopeng, et al.
Publicado: (2021)